GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
115 hedge funds and large institutions have $3.53B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 115 → 115 (0)
51% less call options, than puts
Call options by funds: $31.3M | Put options by funds: $63.9M
Holders
115
Holding in Top 10
3
Calls
$31.3M
Puts
$63.9M
Top Buyers
| 1 | +$96.8M | |
| 2 | +$44.9M | |
| 3 | +$23.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$15.1M |
Top Sellers
| 1 | -$26.4M | |
| 2 | -$10.6M | |
| 3 | -$8.88M | |
| 4 |
D.E. Shaw & Co
New York
|
-$5.94M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$5.5M |